(Q37882050)

24 August 2017

1 reference

title

The Wnt/Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand? (English)

1 reference

24 August 2017

P ter Horst

1

1 reference

24 August 2017

J F M Smits

series ordinal

2

1 reference

24 August 2017

W M Blankesteijn

series ordinal

3

1 reference

24 August 2017

27 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

204

1 reference

24 August 2017

1

1 reference

24 August 2017

110-117

1 reference

Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

What causes a broken heart--molecular insights into heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Beta-catenin downregulation is required for adaptive cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Mouse strain determines the outcome of wound healing after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Myocardial remodeling after infarction: the role of myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Wnt signaling: complexity at the surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Evidence that the cysteine-rich domain of Drosophila Frizzled family receptors is dispensable for transducing Wingless

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

The beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

A role of Dishevelled in relocating Axin to the plasma membrane during wingless signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

GSK3 inhibitors: development and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

The fuzzy logic of physiological cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Predicting mortality and rehospitalization in heart failure patients with home monitoring--the Home CARE pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Myocyte hypertrophy and apoptosis: a balancing act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

The mechanistic basis of infarct healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Hypertrophy of the heart: a new therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Transcriptional genomics associates FOX transcription factors with human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Decisions, decisions: beta-catenin chooses between adhesion and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Disruption of Esrom and Ryk identifies the roof plate boundary as an intermediate target for commissure formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Inhibition of glycogen synthase kinase 3beta during heart failure is protective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Glycogen synthase kinase-3beta -- actively inhibiting hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Multiplicity of the interactions of Wnt proteins and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

beta-catenin destruction complex: insights and questions from a structural perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Regulation of bone mass by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Wnt/frizzled signalling modulates the migration and differentiation of immortalized cardiac fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Re-employment of developmental transcription factors in adult heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Cardiac-specific haploinsufficiency of beta-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Molecular targets and regulators of cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Expression of secreted frizzled related proteins 3 and 4 in human ventricular myocardium correlates with apoptosis related gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Planar cell polarity signaling: from fly development to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Mitogen-activated protein kinases in heart development and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2011.02309.X

10.1111/J.1748-1716.2011.02309.X

21 January 2018

Identifiers

DOI

1 reference

release_yb6wsalpl5eqvce5o4nasziaty

24 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yb6wsalpl5eqvce5o4nasziaty

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference